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Introduction:  Little is known about post-mastectomy reconstruction procedural trends in women diagnosed with breast cancer in England. Our aim was to examine patterns of immediate and delayed reconstruction procedures over time and within regions. 
Methods: Women with breast cancer who underwent unilateral index immediate or delayed post-mastectomy reconstruction between 2007 and 2014 were identified using the national Hospital Episode Statistics database. Women were grouped into categories based on the type of reconstruction procedure. Adjusted rates of implant and free flap reconstructions were then calculated across regional Cancer Networks using a regression model to adjust for age, disease, comorbidities, ethnicity, and deprivation.
Results: Between 2007 and 2014, 21 862 women underwent immediate reconstruction and 8653 delayed reconstruction. Immediate implant reconstruction increased from 30% to 54%, and immediate free flap reconstruction from 17% to 21%. Adjusted immediate implant and free flap proportions ranged from 17% to 68% and 9% to 63%, respectively, across regions. Free flaps became more common in the delayed setting, rising from 25% to 42%.  However, adjusted rates ranged from 23% to 74% across regions. Networks with high / low rates of free flaps for immediate tended to have high / low rates for delayed reconstruction.
Conclusion: There has been a substantial increase in the use of immediate implant reconstruction in England. In comparison, there has been an increasing use of autologous free flap reconstruction for delayed procedures. Significant regional variation exists in the type of reconstruction performed, and these patterns need to be examined to determine if variation is related to service provision and/or capacity barriers. 






The psychosocial impact on women with breast cancer who undergo mastectomy has been well documented. ADDIN EN.CITE (, ) In 2002, the National Institute for Health and Clinical Excellence in the UK recommended that post-mastectomy reconstruction should be available to all women.() Whilst in the US, the 1999 Women’s Health and Cancer Rights mandated that health insurance providers cover reconstruction costs. Subsequently breast cancer care services have evolved, and in numerous countries encouraging evidence indicates a rise in reconstruction uptake.  ADDIN EN.CITE ( ADDIN EN.CITE )
Currently, women have several reconstruction options available to them either at the time of mastectomy or at a later date. These include implants, autologous pedicled flaps with or without implants, and autologous free flap reconstructions.() In recent years, there has been the development of materials that facilitate direct to implant reconstruction such as accellular dermal matrices (ADM) and titanium mesh. 
Studies of immediate breast reconstruction from early 2000s revealed a ratio of 2:1 for autologous to implant procedures. ADDIN EN.CITE (, ) Authors have demonstrated higher patient satisfaction following autologous reconstruction, and greater longevity of aesthetic results at long term follow-up comparative to implant reconstruction. ADDIN EN.CITE (, ) Despite this evidence, a rise in immediate implant procedures has been reported in the US. ADDIN EN.CITE (, ) 





This study used data extracted from the Hospital Episode Statistics (HES) database between 1 January 2000 and 31 March 2014.() This database contains records on all patients admitted to English National Health Service (NHS) hospitals, and allocates patients a unique identifier that allows for longitudinal follow-up.  Each record contains demographic and clinical information including diagnoses, and operative procedures.  Diagnoses are coded using International Classification of Diseases, 10th revision (ICD10),() while procedures are coded using the UK Office for Population Census and Surveys classification, 4th revision (OPCS4).()
The study included women aged 16 years or over with breast cancer (ICD10: C50 and D05) who underwent unilateral initial mastectomy (OPCS4: B27) in English NHS hospitals. Women with previous BCS (OPCS4:B28 excluding B28.4) were excluded because their previous surgery may have affected their reconstruction choice. Women undergoing bilateral mastectomy were also excluded. Women were then grouped into those having immediate reconstruction and those having delayed reconstruction. Immediate reconstruction was identified if a woman had a reconstruction procedure code with the same laterality and date as their mastectomy. Mastectomies occurring between 1 April 2007 and 31 March 2014 were included in our immediate reconstruction group. Delayed reconstruction was identified if women had an index reconstruction procedure occurring between 1 April 2007 and 31 March 2014 with the same laterality as a previous unilateral mastectomy occurring between 1 April 2000 and December 2013. 
Patient variables
Patient age was defined as age at reconstruction. The presence of comorbidities was based on a woman’s RCS Charlson comorbidity score,() with the exception of a diagnosis of breast cancer (which was removed from the list of conditions counted in the Charlson score) as all patients had this diagnosis code. The area-based Index of Multiple Deprivation 2004 (IMD) score was used to measure socioeconomic deprivation, and categorised patients into quintiles from 1 (least deprived) to 5 (most deprived).()  A small number of women without IMD data were excluded as these patients were thought to be overseas visitors (152 women). Ethnicity was grouped into 4 categories: White (including mixed ethnic categories), Asian, Black, or Unknown ethnicity.  Finally, each woman was assigned to one of the 28 English Cancer Networks that existed on 31 March 2012 based on the hospital provider code at mastectomy surgery.  
Outcome definition
Type of reconstruction was grouped in five categories: implant or expander, pedicled flap, pedicled flap with implant or expander, free flap, and non-specific ‘Other’ breast reconstruction code without implant or expander (Appendix 1 for OPCS4 procedure codes). Women were assigned into one of five categories based on their index reconstruction procedure. 
Analysis
The proportion of women in each type of reconstruction category was plotted over time based on reconstruction date for both immediate and delayed reconstruction.  Among women undergoing immediate implant/expander reconstruction, the incidence of concurrent non-specific ‘Other’ breast reconstruction codes was  examined over time to help identify use of materials such as ADM because no OPCS4 code currently exists for this procedure. 





Between April 2007 and March 2014, a total of 21 862 women were identified as having unilateral mastectomy with immediate reconstruction. The annual number of reconstructions increased from 2182 in 2007 (14.9% Immediate Reconstruction rate) to 3753 in 2013 (24.7% Immediate Reconstruction rate). The dominant trend in procedure type was related to implant/expander based reconstructions, rising from 30% of all immediate reconstruction in 2007 to 54% in 2013. The use of free flap procedures increased marginally, the proportion rising from 17% to 21%.  However, pedicled flaps with implant/expander decreased from 28% to 12%. Pedicled flaps without implant/expander also decreased during the study period from 22% to 10%. (Figure 1)
The majority of pedicled flaps were coded as latissimus dorsi flaps, both in those women with and without implant/expanders (99.6% and 91.9%, respectively). Overall, 72.6% of the 4,226 immediate free flaps were coded as DIEPs, and 16.4% as free TRAMS. The proportion of free flaps that were DIEPS increased from 60.2% in 2007 to 79.9% in 2013, whilst the proportion of free TRAMs decreased from 21.0% to 11.5%. In total, 2.5% of women who received free flap reconstruction were coded as having gluteal flaps. The remaining women who received free flap reconstruction were coded as non-specific abdominal free flap procedures (6.1%), or ‘distant’ free flaps (2.5%). 
To identify the use of materials such as ADM in the implant/expander cohort, we examined the frequency with which non-specific ‘Other’ breast reconstruction codes (Appendix 1) were used in combination with these implant/expander OPCS4 codes.  In 2007, 15% of women undergoing implant/expander based immediate reconstruction had additional ‘Other’ coding; however by 2013, this had increased to 44%.  In only those women undergoing implant reconstruction additional coding was identified in 54% of women over the seven years. Whilst in those women receiving expander based reconstruction, a total of 23% of women were identified with additional coding. 
Table 1 describes the distribution of patient characteristics across immediate reconstruction categories, along with the relative risk for implant/expander reconstruction and free flap reconstruction, using the remaining reconstruction categories as the baseline. The likelihood of implant/expander reconstruction relative to age was found to display a bimodal distribution, more likely in women aged 40 years and under, and in women aged over 65 years. The likelihood of free flap reconstruction decreased with increasing age. In women with both invasive and in situ disease, implant/expander reconstruction was less common than among women with invasive or in situ disease alone. Relative to women of white ethnicity, free flap reconstructions were more common immediate reconstruction procedures in women of Asian and Black ethnicity. A greater proportion of women from the most deprived category received implant reconstruction, and had an accompanying lower use of free flap reconstruction. 
 Delayed Reconstruction 
Between April 2007 and March 2014, a total of 8653 delayed reconstructions were identified amongst women having undergone previous unilateral mastectomy. Median time to reconstruction was 692 days (IQR 481-1010 days). The trends in procedure type were dissimilar to those of immediate reconstruction. In the delayed setting, free flaps were the only increasing trend in procedure type, rising from 25% in 2007 to 42% in 2013.  Pedicled flaps, with and without implant/expanders, decreased from 31% and 16%, respectively, to 23% and 11%, respectively. Implant/expander procedures remained roughly stable at around 25%.  (Figure 2)
In those women undergoing delayed pedicled flap procedures without implant/expander, 78.4% were coded as latissimus dorsi reconstructions and the remainder pedicled TRAMs. In women receiving pedicled flaps with implant/expander, 99.4% were latissimus dorsi reconstructions. Overall 67.7% of the 2,953 delayed free flaps were coded as DIEP procedures, and 26.7% free TRAMs. The proportion of free flaps that were DIEPS increased from 45.6% in 2007 to 76.5% in 2013, whilst the proportion of free TRAMs decreased from 39.5% to 20.2%.  Of the remaining women who received delayed free flap reconstruction, a small number were coded as gluteal flap (21 women) or distant flap reconstructions (15 women), and the remainder as non-specific abdominal flap reconstructions. 
Relative to the other reconstruction categories, implant/expander procedures were more common and free flaps less frequent in women aged over 60 years. Relative to those women with invasive disease, implant/expander delayed reconstruction was significantly more likely in women with in situ disease (RRR 2.65, 95% CI 2.07-3.39). Delayed free flap reconstruction was influenced by ethnicity and deprivation in a similar fashion to immediate free flap reconstruction; more likely in women of Asian and Black ethnicity, and less likely in women from the lowest deprivation categories.  (Table 2)
Regional Variation 
Between April 2010 and March 2014, the risk-adjusted proportion of implant based immediate reconstruction ranged from 17% to 68% (Median 48%; IQR 39-57%) across Cancer Networks. The exact number of implant procedures varied from 37 to 607 (Median 198; IQR 160-305).  During the same time period, the number of immediate free flap reconstructions varied from 1 to 516 (Median 86; IQR 25-133). Excluding those Networks that performed less than 50 unilateral immediate free flap reconstructions over the four years (11), the risk-adjusted proportion ranged from 9% to 63% (Median 28%; IQR 13-33%)  amongst the remaining Networks. 
Between April 2010 and March 2014, 12 of the 28 Cancer Networks performed less than 50 delayed free flap reconstructions following unilateral mastectomy. Excluding these Networks, the risk-adjusted proportion of delayed reconstructions that were free flaps ranged from 23 to 74% (Median 43%; IQR 36-56%). 





Between April 2007 and March 2014, there has been a distinct change in types of immediate and delayed post-mastectomy reconstruction procedures being performance within England. Among women with breast cancer undergoing immediate reconstruction, the overwhelming trend was towards implant/expander reconstructions, with proportions rising from 30% to 54%. In those women undergoing delayed reconstruction, however, it was free flap procedures that became more dominant, rising from 25% in 2007 to 42% in 2013. Immediate implant/expander reconstruction was more common in women aged less than 40 years, and in women aged greater than 65 years. In both the immediate and delayed setting, free flap reconstruction was significantly less common in women aged over 60 years, in women from the most deprived categories, but was more common in women of Asian and Black ethnicity. In the delayed setting implant/expander reconstruction was more likely in women with in situ disease, compared to women with invasive disease. 
We further observed that type of reconstruction varied substantially across Cancer Networks in both the immediate and delayed settings and that Cancer Networks’ relative free flap performance was consistently high / low for immediate and delayed reconstruction. 
Strengths and limitations
The study has several strengths.  First, it used a comprehensive national database that included all women undergoing initial unilateral mastectomy over a 13-year period in English NHS hospitals, which reduced the risk of selection bias and yielded a large study cohort. Further, by investigating unilateral mastectomy cases only, a homogenous cohort was ensured. ADDIN EN.CITE (, ) Second, immediate and delayed reconstructions were reported based on reconstruction year allowing for a more accurate representation of current clinical trends. Lastly, we were able to define five specific reconstruction categories, with autologous free flaps subtypes separated from autologous pedicled flaps, thus providing a more informative investigation of procedure type.  
The study has a number of limitations.  The coding of diagnoses and procedures in an administrative hospital database may suffer from errors or omissions. Studies examining the coding of breast cancer surgery within HES, however, concluded that the coding of these procedures is accurate, finding 90-93% agreement with data provided by surgeons in England.() Moreover, there are specific codes for mastectomy and breast reconstruction, which should reduce the risk of mis-classifying operations. We used a wide range of procedure codes to identify reconstruction in order to minimise the effect of different coding patterns within hospitals. Consequently, bias due to errors in procedure coding is likely to be small. 
HES does not contain information on whether procedures were performed with materials such as ADM. Knowing this information would help to further appreciate the trend observed in immediate reconstruction. We investigated the incidence of concurrent non-specific ‘other’ breast reconstruction coding in  those women having implant/expander reconstruction as a way of overcoming this weakness, but we can only hypothesis that the substantial increase in the concurrent use of “other” reconstruction codes corresponds to the greater use of ADM.   
Another limitation is that HES also does not contain information on tumour size, disease stage, or adjuvant therapy. Reconstruction procedure type will likely be influenced by these variables. However, two separate studies have shown non-significant variation in breast cancer stage at presentation across Cancer Network regions. ADDIN EN.CITE (, ) Adjusting for tumour size, disease stage or adjuvant therapies would therefore be unlikely to significantly reduce the between-Network variation that was observed.
Clinical implications
In the US, the trend towards immediate implant based procedures is even more pronounced than the trend we observed in England.  This is likely to be attributable to the advent of materials such as ADM facilitating a direct to implant reconstruction. Cemal et al reported national implant procedures to rise from 39% of all unilateral immediate reconstructions in 1998, to 63% in 2008.() Autologous immediate reconstruction has similarly decreased in the US from 59% in 1998 to 32% in 2008. ADDIN EN.CITE ()
Whilst experience with implants is improving, particularly in the setting of Radiotherapy, ADDIN EN.CITE (, )()  the results from our study and the US are surprising when considering several outcome studies. Authors have not only found autologous reconstruction to be more stable, with greater longevity of aesthetic results, but Patient Reported Outcome Measures (PROMS) following free flap reconstruction are significantly higher. ADDIN EN.CITE (, )()
Patient choice may offer an explanation. Women with breast cancer have far greater access to information in recent years, and authors have shown women to favour a quick recovery that avoids donor site morbidity. ADDIN EN.CITE () We observed that women of Black and Asian ethnicity were more likely to receive free flap reconstruction comparative to women of white ethnicity, an opposite trend to that reported in the US. ADDIN EN.CITE (, ) In the UK, the majority of Black women are diagnosed when aged less than 50 years, and this may impact reconstruction choice. Further, women of Black and Asian ethnicity are more likely to live in urban cities where Cancer Networks are high free flap performers. ADDIN EN.CITE ()  Patient procedural choice has not previously been examined in relation to ethnicity. Nonetheless, patient preference and ethnic influences would be unlikely to account for an IQR of 20.0% in risk adjusted rates of immediate implant/expander reconstruction observed across Networks. 
Given the degree of regional variation, the organisation of breast cancer services needs to be considered. The national mastectomy and breast reconstruction audit received substantial attention, and English breast cancer services have faced pressure to ensure immediate reconstruction is available to all women.()  With rates of immediate reconstruction in England rising from 10% in 2005 to 23% in 2013, workforce availability is key. ADDIN EN.CITE () For example, immediate autologous reconstruction takes considerable longer than an implant procedure and as such may be subject to operating room capacity barriers within cancer waiting targets. ADDIN EN.CITE () It is known that the distribution of microsurgical breast surgeons varies across the country in the US and Europe, and indeed we found risk adjusted rates of immediate free flap reconstructions to range from 9 to 63% (IQR 20.4%) across Cancer Networks. ADDIN EN.CITE (, ) This regional variation has also been shown in the US. ADDIN EN.CITE ()
In the delayed setting, such pressures are lacking because the cancer has been previously treated, and here, we found free flap reconstruction was becoming increasing common, rising from 25% to 42%. The more complex reconstruction needs in the delayed setting such as the requirement for skin, alongside the potential of an irradiated field are likely to influence this observed difference in procedural trends. Indeed in women with in situ disease, who are less likely to have received radiotherapy, we found that delayed implant reconstruction was significantly more likely. However, it should be noted that even in the delayed setting, similar regional variation in free flap practice was observed with adjusted rates ranging from 23% to 74%. We are not aware of previous longitudinal studies or regional trends for delayed reconstruction being reported at a national level outside the UK. ADDIN EN.CITE () 
A study from the US has speculated that cost may influence reconstructive practice. Surgeons’ hourly rate for an implant reconstruction in the US is $587, whilst for an autologous procedure is $322.()  Given these procedural reimbursement policies, this may well explain the pronounced trend toward implant-based reconstructions in the US. Nonetheless, we found a similar trend towards immediate implant reconstruction in English NHS hospitals, where surgeons’ payment is not influenced by the procedure they perform. In the UK, it is the hospital that receives payment based on procedure type according to the NHS National Tariff Payment System.() Tariffs are defined nationally and aligned to promote efficiency and high quality care. The actual cost of performing certain procedures can exceed the income that hospitals receive. In terms of breast reconstruction, income from immediate free flap reconstruction has been shown to substantially undercut costs. ADDIN EN.CITE () Atherton et al investigated women undergoing immediate breast reconstruction, and found a net loss in income of £794 for implant procedures, £1592 for free DIEP procedures, and £2853 for free TRAM procedures. ADDIN EN.CITE () 






Our study found a significant trend toward implant based immediate post-mastectomy reconstruction, rising from 30% in 2007 to 54% in 2013. In the delayed setting, free flap procedures were the dominant trend, rising from 25% to 42% over the seven-year study period. In both immediate and delayed reconstructions, age, deprivation, and ethnicity influenced a woman’s likelihood of receiving free flap reconstruction. Substantial variation in type of reconstruction was observed across the regional Cancer Networks and their relative free flap performance was consistently high or low for both immediate and delayed reconstructions. 








ICD10	International Classification of Diseases, 10th revision
IMD	Index of Multiple Deprivation
NHS	National Health Service 
OPCS4	Office for Population Census and Surveys classification, 4th revision
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APPENDIX 1: Categorisation of reconstruction categories by OPCS4 codes.
Reconstruction Category	OPCS4 Procedure Combination	OPCS4 Code
Implant/ Expander	Insertion of prosthesis for breastOther/Unspecified prosthesis for breastInsertion of skin expander into subcutaneous tissue of breast 	B30.1B30.8/B30.9S48.2
Pedicled Flap 	Reconstruction of the breast using Latissimus dorsiReconstruction of breast using Pedicled TRAM	B29.1B39.2
Pedicled Flap + Implant/Expander	Latissimus dorsi/Pedicled TRAM+ Implant/Expander	B29.1/B39.2B30.1,B30.8, B30.9/S48.2
Free flap 	Reconstruction of the breast using Free DIEPReconstruction of the breast using Free TRAMOther/Unspecified reconstruction of breast using abdominal flap Reconstruction of breast using flap of skin of abdomenReconstruction of the breast using free superior/ inferior Gluteal artery perforator flapOther/Unspecified reconstruction of breast using flap of skin of buttockReconstruction of breast using distant flap of skin	B39.3B39.1B39.8/B39.9B29.3B38.1/B38.2B38.8/B38.9B29.4






Table 1: Number, proportion, and multinomial relative risk of immediate implant/expander reconstruction, or immediate free flap reconstruction, across patient variables Pedicled flaps with, and without implant/expander, and non-specific reconstruction categories were used as the baseline. Year runs from April-March.
	Number of Immediate Reconstructions	Implant/Expander n (%)	Free flapsn (%)	Implant/ExpanderRRR (95% CI)	Free flapsRRR (95% CI)	p
Age (years):min-4041-4546-5051-5556-6061-6565-7071+	2687305248544024280425031359579	1254 (46.7)1292 (42.3)2033 (41.9)1638 (40.7)1071 (38.2)1058 (42.3)    680 (50.0)    308 (53.2)	   463 (17.2)   620 (20.3)1023 (21.1)   874 (21.7)   600 (21.4)   420 (16.8)      171 (12.6)   55 (9.5)	1.20 (1.07,1.33)1.06 (0.96,1.18)11.00 (0.91,1.10)0.90 (0.81,1.00)0.96 (0.86,1.07)1.16 (1.01, 1.32)1.23 (1.02,1.49)	0.86 (0.75,0.98)0.98 (0.86,1.11)11.05 (0.93,1.17)0.99 (0.87,1.12)0.75 (0.65,0.86)0.59 (0.49, 0.72)0.45 (0.33,0.62)	<0.001
DiseaseInvasiveDCISInvasive & DCIS	14 97033063586	6520 (43.6)1429 (43.2)1385 (38.6)	2813 (18.8)    632 (19.1)    781 (21.8)	11.06 (0.97,1.16)0.88 (0.81,0.95)	10.99 (0.89,1.10)1.08 (0.97,1.19)	<0.001
Number of comorbidities 0 1 >1	 15 3485700814	6306 (41.1)2622 (46.0)    406 (49.9)	3156 (20.6)    952 (16.7)    118 (14.5)	11.07 (1.00, 1.15)1.13 (0.97, 1.33)	10.80 (0.73,0.87)0.70 (0.56,0.87)	<0.001
EthnicityWhiteAsianBlackUnknown	19 844704625689	8491 (42.8)    299 (42.5)    215 (34.4)    329 (47.8)	3698 (18.6)    194 (27.6)    221 (35.4)    113 (16.4)	11.19 (0.99,1.43)0.93 (0.76,1.14)1.10 (0.93, 1.31)	11.87 (1.53,2.29)2.44 (1.99,3.00)0.86 (0.68,1.08)	<0.001
Deprivation1 (least)2345 (most)	56315047442137772986	2346 (41.7)2101 (41.6)1861 (42.1)1597 (42.3)1429 (47.9)	1105 (19.6)    986 (19.5)    851 (19.2)    782 (20.7)    502 (16.8)	11.00 (0.91,1.09)1.01 (0.92,1.10)1.05 (0.96,1.16)1.24 (1.12,1.37)	10.98 (0.88,1.09)0.96 (0.86,1.07)1.03 (0.91,1.15)0.82 (0.72,0.94)	<0.001




Table 2: Number, proportion, and multinomial relative risk of  delayed implant/expander reconstruction, or delayed free flap reconstruction, across patient variables. Delayed pedicled flaps with, and without implant/expander, and non-specific reconstruction categories were used as the baseline. Year runs from April-March

	Number of DelayedReconstructions	Implant/Expander n (%)	Free flapsn (%)	Implant/ExpanderRRR (95% CI)	Free flapsRRR (95% CI)	p
Age (years):min-4041-4546-5051-5556-6061-6565-7071+	9691336193117201111885484217	238 (24.6)270 (20.2)401 (20.8)357 (20.8)255 (23.0)272 (30.7)159 (32.9)  97 (44.7)	318 (32.8)480 (35.9)726 (37.6) 669 (28.9) 366 (32.9)248 (28.0) 117 (24.2)  29 (13.4)	1.16 (0.95,1.42)0.92 (0.76,1.11)11.01 (0.84,1.20)1.03 (0.85,1.25)1.43 (1.18,1.75)1.42 (1.11,1.81)2.05 (1.50,2.81)	0.85 (0.71,1.02)0.92 (0.79,1.08)11.07 (0.93,1.25)0.85 (0.72,1.01)0.76 (0.62,0.92)0.61 (0.47,0.79)0.33 (0.21,0.51)	<0.001
DiseaseInvasiveDCISInvasive & DCISUnspecified 	748037674651	1678 (22.4)   169 (45.0)   176 (23.6)     26 (51.0)	2594 (34.7)     90 (23.9)   258 (34.6)	     11 (21.6)	12.65 (2.07,3.39)1.11 (0.91,1.35)3.57 (1.84,6.92)	11.00 (0.75,1.32)1.05 (0.88,1.25)0.96 (0.43,2.13)	<0.001
Number of comorbidities 0 1 >1	 68631,571219	1585 (23.1)   398 (25.3)     66 (30.1)	2443 (35.6)    443 (28.2)     67 (30.6)	10.99 (0.86, 1.14)1.30 (0.93, 1.80)	10.66 (0.58,0.75)0.89 (0.64,1.24)	<0.001
EthnicityWhiteAsianBlackUnknown	825920312566	1977 (23.9)     37 (18.2)     23 (18.4)     12 (18.2)	2778 (33.6)     99 (48.7)     54 (43.2)     22 (33.3)	10.98 (0.65,1.47)0.86 (0.52,1.43)0.65 (0.33,1.26)	11.90 (1.38,2.62)1.61 (1.07,2.41)0.77 (0.44,1.33)	<0.001
Deprivation1 (least)2345 (most)	24712039169314331017	572 (23.1)449 (22.0)374 (22.1)381 (26.6)273 (26.8)	911 (36.9) 757 (37.1) 596 (35.2) 440 (30.7) 249 (24.5)	10.92 (0.79,1.07)0.89 (0.75,1.05)1.09 (0.92,1.28)0.98 (0.81,1.18)	10.99 (0.87,1.14)0.90 (0.78,1.04)0.75 (0.65,0.88)0.52 (0.43,0.62)	<0.001






Table 3: Risk-adjusted immediate and delayed free flap rankings correlated across Cancer Networks during April 2010 and March 2014. Only those Networks performing more than 50 unilateral free flap procedures in either the delayed or immediate setting were included.  Networks are ordered for immediate reconstruction, where red equates to the lowest rank, and blue the highest rank. 

































Figure 2: Proportional trend over time of type of delayed reconstruction procedure performed across the English National Health Service following unilateral index mastectomy. Year based on reconstruction year.
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